Due to the expression of adiponectin mRNA in obese patients and the lower expression level in plasma, we can treat insulin resistance by supplementing adiponectin in the body to avoid the development of type 2 diabetes. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.